|
|
|
|
| TRADING CENTER |
56.25+0.87 / +1.57%
Amgen Inc (NASDAQ GS:AMGN)
56.21-0.04 / -0.08
After hours quote
Prev. Close:
55.38
Open:
55.82
High:
56.59
Low:
55.75
Volume:
5,033,553
Volume Avg.:
7,490,700
52wk Range:
44.96 - 64.76
Market Cap (mil):
56,932.76
P/E Ratio:
10.76
Dividend Yield:
N/A
| Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards - PR Newswire | |
| 5 Top Stocks at Half Price - MotleyFool.com | |
| 7 Stocks That Are Swimming in Cash - MotleyFool.com | |
| WRAPUP 11-Healthcare bill passes first U.S. Senate test - Reuters | |
| WRAPUP 10-Healthcare bill passes first U.S. Senate test - Reuters | |
| WRAPUP 8-Healthcare bill poised to pass U.S. Senate test - Reuters | |
| WRAPUP 7-Health bill poised to pass U.S. Senate test - Reuters | |
| WRAPUP 6-Healthcare bill gains ahead of U.S. Senate test - Reuters | |
| WRAPUP 5-Healthcare bill gains ahead of U.S. Senate test - Reuters | |
| This Stock Is a Train Wreck - MotleyFool.com | |
| Healthcare stocks not unduly hurt by Senate plan - Reuters | |
| Follow the Smart Money - MotleyFool.com | |
| Allergan, Medicis fall on health plan proposal - Reuters | |
| The Type of Stock You Should Never, Ever Buy - MotleyFool.com | |
| These Stocks Will Burn You - MotleyFool.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | 47.01 | 0.62 / 1.34% | 18.15 |
| CELG | Celgene Corporation | 55.65 | 0.74 / 1.35% | 67.05 |
| BIIB | Biogen Idec Inc | 46.79 | 0.41 / 0.88% | 15.70 |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
14,737,921
Short Interest Ratio:
1.9
Float:
1,014,454,834
Short Interest as a % of Float:
1.4%
Average Daily Volume:
8,439,300
Outstanding Shares:
1,012,138,434
Amgen Inc. is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. It operates in one business segment - human therapeutics. The company markets human therapeutic products mainly in the areas of ... (more)
| 2008 Revenue: | $15.0 B | Headquarters: Thousand Oaks, CA |
| Employees: | 17,400 | CEO: Kevin W. Sharer |
| Net Income: | $4.2 B | Industry: Biotechnology |
| Market Cap: | $56.1 B | Website: www.amgen.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| AMGN | 56.25 | +0.87 / +1.57% | 55.38 | 56.59 | 55.75 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
